Gerber Kawasaki Wealth & Investment Management Vista Gen Therapeutics, Inc. Transaction History

Gerber Kawasaki Wealth & Investment Management

$1.98 Billion
Q2 2024

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2021 Feb 11, 2022	SELL	$1.67 - $2.76 $240 - $397	-144 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$2.62 - $3.45 $377 - $496	144 New	144 $0

Others Institutions Holding VTGN

# of Institutions

Shares Held

2.7M

Call Options Held

Put Options Held

Tcg Crossover Management, LLC Palo Alto, CA

2.68M
Shares

$8.7 Million
1.39% of portfolio
Personal Capital Advisors Corp

27.1K
Shares

$88,075
0.0% of portfolio

View Full List

About VistaGen Therapeutics, Inc.

Ticker VTGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 206,836,000
Market Cap $672M
Description
VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing various medicines with the potential to care for anxiety, depression, and other disorders of the central nervous system (CNS). The company's CNS pipeline includes PH94B, a rapid-onset neuroactive nasal spray, which is in Phase III d...

More about VTGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gerber Kawasaki Wealth & Investment Management, based on Form 13F filings with the SEC.

News

Stay updated on Gerber Kawasaki Wealth & Investment Management with notifications on news.

Account